Cellectar Biosciences, Inc. (CLRB) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Price / Book | 0.82 |
| FCF Yield | -84.3% |
| Sector P/E (Healthcare) | 21.7 |
CLRB overview · CLRB earnings · CLRB KPIs · CLRB investor relations · CLRB ownership · CLRB peers · CLRB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.